M&A Advisors in Hoboken

Background: A subsidiary of an enterprise founded in 1993 and headquartered in Beijing, we are a leading investment, operation, and management group in China, with a presence in over 50 countries globally and annual sales of approximately RMB200 bn (c. US$30.8 bn1). • The pharmaceutical and healthcare business represents a core. Focus area for the group and comprises 40+ companies with total sales of. RMB38 bn (US$5.8 bn) in 2017. • On a consolidated basis, we ranked among the top 5 manufacturers by sales in the Chinese pharmaceutical market in 2017. • We have established four major industrial platforms: (i) Generic pharma; (ii) Specialty pharma; (iii) Traditional Chinese Medicine (TCM); and (iv) bio-pharmaceuticals. Our focus is a cross-border and domestic license (license-in, including both clinical stage and commercial-stage products), tech transfer, acquisition, distribution, and co-development of live biotherapeutic products, and investment in novel microbiome Research platforms.

Background: We are a business consulting and advisory firm. We do not charge upfront fee. We charge only success fee post the deal closure.

Background: We provide advisory services in the M&A segment to our clients. We do not charge an upfront fee. We do charge a success fee. Our clients are interested in business opportunities in North America, Europe and Germany as it is convenient for them to collaborate with businesses in these countries.

Background: We provide advisory services in the M&A segment to our clients. We do not charge an upfront fee. We do charge a success fee. Our clients are interested in business opportunities in North America, Europe and Germany as it is convenient for them to collaborate with businesses in these countries.

Background: Primary Industries: Financial Technology (Fintech) Cryptocurrency & Digital Assets. Payment Services. Gaming & Gambling. Asset Management & Funds. Corporate Services. Regulatory Compliance. Specific Service Areas: Trust and Company Services. Corporate Structuring & Formation. Regulatory Licensing & Authorization. Financial Services Licensing. Money Services Business (MSB) Formation. Crypto Asset Service Provider (CASP) Licensing. MiCA Compliance & Authorization. Electronic Money Institution (EMI) Licensing. Payment Institution (PI) Licensing. Alternative Investment Fund Management (AIFM) Small Fund Structuring. Online Gaming & Gambling Licensing. Virtual Casino Licensing. EU Company Formation. Cross-border Corporate Structuring. Banking Integration & Payment Solutions. Compliance Frameworks (AML/KYC/CTF) Financial Advisory Services. Mergers & Acquisitions (M&A) Advisory. Corporate Finance Advisory. Due Diligence Services. Corporate Restructuring. International Tax Planning. Regulatory Strategy Consulting. Geographic Focus: European Union (Estonia-based operations) Canada (MSB & Financial Services) Cross-border/Multi-jurisdictional structures. Target Clients: Fintech founders & startups. Crypto entrepreneurs. International businesses. Investment fund managers. Gaming operators. Payment service providers.

Background: Great product but needs financing or sales channels to scale.